Table 5 Baseline characteristics of 117 patients with PAs-induced HSOS at the time of diagnosis

Number of patients

44

28

Age, years

59.00 (47.25–63.00)

61.00 (51.25–65.50)

0.60

Male Sex; n (%)

31.00 (70.50%)

20.00 (71.40%)

0.42

Erythrocytes, 10¹²/L

4.58 (4.11–4.86)

4.44 (4.07–4.99)

0.88

Hemoglobin, g/L

140.00 (128.25–149.75)

139.00 (120.00–154.00)

0.84

Leukocyte, 10⁹/L

5.98 (4.59–7.43)

7.51 (5.30–8.73)

0.44

Platelet, 10⁹/L

110.00 (79.00–168.50)

101.00 (73.00–137.00)

0.30

PT, S

16.40 (15.20–18.70)

17.00 (16.20–18.70)

0.53

INR

1.35 (1.23–1.58)

1.41 (1.29–1.60)

0.48

ALT, U/L

68.00 (41.00–147.00)

82.00 (39.00–203.00)

0.35

AST, U/L

88.00 (59.00–166.00)

108.00 (63.00–197.00)

0.40

Total bilirubin, μmol/L

37.25 (21.80–69.98)

39.15 (26.03–122.75)

0.07

ALB, g/l

32.60 (28.20–34.95)

29.85 (27.75–32.18)

0.44

Urea, mmol/L

6.10 (4.12–7.70)

5.83 (4.26–8.77)

0.34

Creatinine, μmol/L

77.50 (64.35–87.32)

81.95 (66.42–97.40)

0.30